Skip to main content
BioAdvance NewsKayotheraPortfolio News

KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million

By July 19, 2023November 1st, 2024No Comments

KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million

New funding comprised of grants from the National Institutes of Health, The Andy Hill Cancer Research Endowment (CARE) Fund, and additional Equity Funding

Additional funding will support advancement of KayoThera’s development programs in diabetes and oncology

See more here